Accuray To Report Fiscal 2020 First Quarter Financial Results on October 29, 2019

SUNNYVALE, Calif., Oct. 10, 2019 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2019 on Tuesday, October 29, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 855-859-2056 (USA), or 404-537-3406 (International), Conference ID: 4191278.

A live webcast of the call will also be available from the Investor Relations section of the Company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2020.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and sells radiotherapy systems that are intended to make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.

Contacts:

Investor Contacts:           
Michael Polyviou
EVC Group LLC 
732-933-2754
mpolyviou@evcgroup.com

Media Contacts
Beth Kaplan
Accuray Inc
+1 (408) 789-4426
bkaplan@accuray.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2020-first-quarter-financial-results-on-october-29-2019-300936793.html

SOURCE Accuray Incorporated

Staff

Recent Posts

Signum Surgical Granted FDA De Novo Clearance for BioHealx™

Novel surgical option for the treatment of anal fistula, a painful and debilitating colorectal condition…

2 hours ago

IRLAB: Invitation to the Interim Report for Q2 2024 Presentation and Webcast

GOTHENBURG, SE / ACCESSWIRE / July 08, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…

2 hours ago

Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine

MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…

3 days ago

Hospital PMI® at 55.8%; June 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…

3 days ago

KORE Helps mCare Digital Launch the Next Generation of Personal Emergency Technology

mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…

3 days ago